ACS Medicinal Chemistry Letters · 2020 · 74 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationChemical Library DesignChemical Space ExplorationLead Compound DesignLigand BindingLigand-based DesignProtein-ligand DockingEarly Drug DiscoveryPyrrolidine SynthesisScaffold Structural AnalysisStructure-based De Novo DesignStructure-based Lead DiscoveryStructure-based Lead IdentificationStructure-based Ligand Design
The pressure to deliver new medicines to the patient continues to grow along with increases in compound failure rate, thus putting the current R&D model at risk. Analysis has shown that increasing the three-dimensionality of potential drug candidates decreases the risk of failure and improves binding selectivity and frequency. For this reason many workers have taken a new look at the power of photochemistry as a means to generate novel sp3 rich scaffolds for use in drug discovery programs. Here we report the design, synthesis, and computational structural analysis of a series of 2,4-methanoprolines having inherent 3D character (PMI and PBF scores) significantly higher than that of the broader AbbVie Rule of 3 (Ro3) collection.
15
Escape from Flatland 2: complexity and promiscuity
Frank Lovering · MedChemComm · 2012 · 1.4K citations
Paul A. Clemons, Nicole E. Bodycombe, Hyman A. Carrinski et al. · Proceedings of the National Academy of Sciences · 2010 · 352 citations · Full text